Effect of darbepoetin alfa on quality of life in anemia of chronic kidney disease elderly patients with type 2 diabetes mellitus - Effect of darbepoetin alfa for on diabetic elderly patients with renal anemia

Graduate School of Medicine, Chiba University0 个研究点目标入组 12 人开始时间: 2012年4月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with cognitive impairment and on the anti cognitive impairment drug 2) Patients with impossible control of hypertension 3) Patients with impossible glycemic control 4) Patients with congestive heart failure 5) Patients with major surgery within 16 weeks 6) Patients with red blood cell (RBC) transfusions within 16 weeks 7) Patients receiving anabolic steroid hormone, testosterone enanthate, mepitiostane within 16 weeks 8) Patients with anemia caused by conditions other than renal anemia such as GI bleeding and blood desease 9) Patients with history of stroke, MI or other sever vascular complication which required a hospitalization 10) Patients with serious allergies or serious drug sensitivities 11) Patients with serious liver dysfunction (ALT or AST greater than 2 times the upper limit of hpspital standard) 12) Patients with scheduled to receive a renal replacement therapy 13) Patients having hypersensitivity to rHuEPO 14) Other patients determined to be inappropriate by physician

发起方

Graduate School of Medicine, Chiba University